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Introduction
The low sensitivity of ultrasonography (US) in diagnosing axillary
lymph node metastasis in breast cancer patients has sparked the
evaluation of various tools in an attempt to increase pre-operative
sensitivity. We compared axillary lymph node metastasis probability
scores with post-surgical findings, using the Memorial Sloan Kettering
Cancer Centre (MSKCC) nomogram and Evidencio, two freely available
online predictor tools.
Methods
We retrospectively evaluated 450 breast cancer patients and ana-
lysed data from 194 patients. Ultrasound images were evaluated to
assess axillary lymph node status. Patients were divided into groups
0, 1 or ≥2 nodes based on the number of post-operative positive
nodes. The difference in mean scores across the 3 nodal groups for
both nomograms was analysed using the one-way ANOVA test. The
Nottingham Prognostic Index (NPI) was also calculated for each patient.
Data was analysed using SPSS ver20 and p<0.05 was considered statis-
tically significant.
Results
There were significant differences in mean scores across the 3 nodal
groups when using MSKCC (p= 0.000), and Evidencio (p= 0.000). A
strong positive correlation was found between MSKCC, Evidencio
and NPI. (rs = 0.671 (MSKCC vs. Evidencio), rs = 0.721 (Evidencio vs.
NPI), rs = 0.656 (MSKCC vs. NPI), p= 0.000 (for all)).
Conclusion
Both MSKCC and Evidencio nomograms can be used to predict
axillary node metastasis and guide patient management. Further
evaluation is recommended before omitting Sentinel Lymph Node
Biopsy or Axillary Node Dissection in patients with very low scores
and prompting a ‘second look’ US in patients with high scores.O2
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Pre-operative staging of the axilla is mandated. In 2011 the ACOSOG
Z0011 trial indicated that women with small (T1 – T2) breast cancers
and ≤2 nodes positive at SLNB may not require axillary clearance,
resulting in a change to surgical practice. Pre-operative ultrasound is
still routine despite studies showing between 38% and 46% of symp-
tomatic women with positive pre-operative staging had ≤2 nodes
positive at surgery and were thus potentially overtreated or eligible
for the POSNOC trial. We measured the impact of current staging in
one UK breast screening service.
Method
Data were extracted from the unit’s National Breast Screening com-
puter System between 01/04/2008 and 31/03/2015. Axillary staging
was compared with final pathology and treatment.
Results
164 of 776(21.1%) invasive cancers were node positive. 90 (11.6%)
had an axillary biopsy, 54 were positive for cancer (32.9% of the
node positive cases). Of these 22 (40.7%) had neoadjuvant treatment,
32 (59.3%) proceeded directly to axillary clearance (mean node count
14.6). 17 (53%) of those who had axillary clearance had ≤2 positive
nodes. This compares with 82% of node positive women with a
negative biopsy and 74% of node positive women with a normal
ultrasound.
Summary
This small series suggests significant numbers of women are being
denied entry into POSNOC or being potentially overtreated because
of routine pre-operative axillary staging. A much larger data set is
required to confirm this and predict who would benefit from pre-
operative axillary staging. A bid to use the whole ABS data set is
with CRUK.
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Introduction
To determine the rate and classification of interval breast cancer (IC)
in the two years preceeding and following the introduction of digital
mammography in 2011 in a national screening programme.
Methods
Two 2-year bands were used to ensure completed data for pre and
post digital groups. Retrospective analysis of a prospectively collected
database of IC was undertaken, identifying women who had under-
gone screening in the two years prior to and after the introduction of
digital screening mammography (1.1.10 until 31.12.11 and 1.1.12 untille is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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the two groups and the rate of false negative (FN) and minimal signs
(MS) categories considered together.
Results
Of 87,868 screened before digital between 1.1.10 and 31.12.11, 103
developed IC (0.12%) and of 100,672 screened with digital between
1.1.12 and 31.12.13, 145 developed IC (0.14%) (p = 0.12). Those
women with FN and MS interval cancer numbered 17 (16.5%) predi-
gital and 41 (28.3%) with digital; (p = 0.04). The number of true IC
was similar in the pre (49.5%) and post (46.9%) groups.
Conclusion
The rate if IC is similar to the NHSBSP standard (1.2 per 1000 women
screened). Despite earlier groups indicating that digital technology
will lessen the number of IC, especially those ‘missed’ (FN and MS
groups) which are often asymmetric densities and poorly defined
masses, this has not been found in our study. The reasons for this
will be discussed and examples will be shown.
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Introduction
In the Republic of Ireland, national quality assurance standards state
that patients over the age of 35 presenting with breast symptoms
should routinely have two-view mammogramography. Our aim was
to determine the breast cancer detection rate in women aged 35-39
with low risk factor profiles and normal clinical examinations.
Methods
A retrospective analysis of all mammograms performed in patients
aged 35-39 at our institution from 2011-2015 was performed. Patients
with moderate or high familial risk, previous breast cancer or chest
radiation, males, GP and internal hospital referrals, and those with ab-
normal clinical examinations were excluded. Included women had “nor-
mal”, “benign” or undocumented examinations. Results of imaging
including subsequent ultrasound and histopathological information
was obtained from EPR and PACS systems.
Results
4,087 patients aged 35-39 had bilateral mammograms from 2011-2015.
2,149 patients were excluded from analysis.
Of 1,938 included women, 4 (0.21%) were diagnosed with breast
cancer confirmed at histology: 2 cases of invasive ductal carcinoma
(8 and 2mm) and 2 of DCIS (4.5mm high-grade-DCIS and 2mm low-
grade-DCIS). Other histological findings included 2 B3, 40 B2 and 2
B1 lesions resulting from mammographic screening. Overall, 114
biopsies were performed; biopsy rate of 6.09%. 69 (60.53%) were
undertaken due to mammographic findings.
Conclusion
2.1 cases of cancer were detected per 1000 women screened. This
figure would be below accepted international thresholds to undertake
screening mammography and raises radiation protection issues. Add-
itionally, a large number of benign biopsies were performed with inher-
ent anticipated psychological impact. Further studies could inform
national guidance.
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Introduction
NHSBSP standards for assessment recall in prevalent screen is a mini-
mum of <10% with a target of <7%. Aims:
(i) review variation in recall rate(ii) assess differences in practice and learn from units performing well
Methods
Prevalent recall rate for the last 3 years in units were collated and a
questionnaire titled ‘NHSBSP Prevalent Round Survey’ designed with
units invited to partake on Survey Monkey.
Results
Only 24% (19/80) of units achieved a prevalent recall rate of <7% for 3
consecutive years and 25% (20/80) of units had a recall of ≥10% at least
once in the last 3 years. In total, 49% (39/80) of units responded:
Reader skill mix and volume
(i) in units with recall of ≥10%, 86% (6/7) have <50% consultant
radiologists in film reading team, compared with 22% (7/32) in
units with a recall of <10%.
(ii) in 67% (14/21) of units with recall of <7%, all readers achieved
target of ≥5,000 mammograms/year, compared with 44% (8/18)
in units with ≥7%.
Prevalent arbitration
(i) 5% (2/39) have specific prevalent arbitration with arbitration of
all potential recalls.
(ii) 21% (8/39) have a policy for lesion types that do not require
recall; 22% (7/32) with recall <10% and 14% (1/7) with recall
≥10%. This includes benign masses, physiological asymmetries
and scattered benign calcifications.
Conclusion
Units with lower prevalent recall rates have a higher proportion of con-
sultant radiologists and higher volume readers. Policy for lesions that do
not require recall can reduce unnecessary assessment of benign lesions.O6
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Introduction
Breast density is a strong risk factor for breast cancer and has potential
use in breast cancer risk prediction, with subjective methods of density
assessment providing a strong relationship with the development of
breast cancer. This study aims to assess intra- and inter-observer vari-
ability in visual density assessment recorded on Visual Analogue Scales
(VAS) among 11 trained readers, and hence the reproducibility over
time.
Methods
11 readers of varying years of experience estimated the breast dens-
ity of 120 mammograms on two occasions 3 years apart using VAS.
Percent breast density was estimated on VAS score sheets and were
scanned using custom software which converted the marks to per-
centages. Intra- and inter-observer agreement was assessed with
intraclass correlation coefficient (ICC) and variation between readers
visualised on Bland-Altman plots.
Results
Excellent intra-observer agreement (ICC>0.81) was found in majority of
the readers. All but one reader had a mean difference <10 percentage
points from the first to second reading. Inter-observer agreement was
excellent for consistency (ICC 0.82) and substantial for absolute agree-
ment (ICC 0.69). However, the 95% limits of agreement for pairwise
Breast Cancer Research 2016, 18(Suppl 1):107 Page 3 of 20differences were (-6.8 to 15.7) at the narrowest and (0.8 to 62.3) at the
widest.
Conclusion
Overall, the readers were consistent in their scores, although some
large inter-observer variations were observed. Reader evaluation and
targeted training may alleviate this problem. Intra-observer readings
are reliable and may be used in monitoring change in breast density
over time, for example when assessing the efficacy of chemopreventive
therapies.
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Introduction
To assess the performance and accuracy of pre-operative Ultrasound
evaluation of axillary lymph nodes in patients with breast cancer.
Methods
All patients who underwent wide local excision or mastectomy for
invasive primary breast carcinoma in a UK district general hospital
between July- Dec 2015 were identified retrospectively and included
in the study. Patients who underwent neo-adjuvant chemotherapy
were excluded from the study.
Results
Out of 94 patients with invasive breast carcinoma included in the
study, 38 patients had abnormal axillary nodes on ultrasound and
subsequent ultrasound guided axillary nodal biopsy (UANB), of which
16 had metastatic carcinoma from primary invasive breast carcinoma
which was later confirmed on axillary nodal clearance (ANC). The
remaining 22 patients underwent sentinel lymph node biopsy (SLNB)
and had no malignant cells on histology.
Of the 56 patients who had normal pre-operative axillary ultrasound,
11 patients were found to have axillary nodal metastatic disease and
45 patients had no malignant cells on subsequent SLNB.
In total, 27(n=94) patients were found to have axillary nodal metastases
in our study.
The positive predictive value of preoperative UANB in detecting
axillary nodal metastatic disease is 42% (16/38) and the negative
predictive value is 80% (45/56). The sensitivity of axillary ultrasound
biopsy is 59% (16/27) and specificity is 67% (45/67). There were 22
false positive cases and 11 false negative cases.
Conclusion
The performance and accuracy of pre-operative ultrasound guided
axillary nodal biopsy in detecting metastatic axillary nodal disease in
our unit remains acceptable within published standards.PB.2
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Introduction
Sentinel lymph node biopsy (SLNB) is the gold standard for axillary
staging. Contrast enhanced ultrasound (CEUS), is a new technique for
pre-operative identification, localization and biopsy of SLNs.
Objective
Evaluate, in patients with breast cancer and normal axillary B-mode
ultrasound, whether: 1) CEUS guided core biopsy of the SLN could
identify metastatic nodes pre-operatively and reduce the number ofsurgical SLNBs. 2) establish whether CEUS SLN identification and
localization is a viable alternative to standard lymphatic mapping
using isotope and blue dye.
Methods
Search of several electronic databases performed. Methodological
quality assessed using QUADAS-2. Pooled estimate of sensitivity and
specificity for identification of nodal metastases were calculated.
Results
Eleven prospective and one retrospective studies with 1520 partici-
pants were included. The SLN identification and localization rate for
CEUS guided skin marking was 70% - 100%, CEUS guided wire
localization 89% - 97% and CEUS guided I-125 seed localization
60%. Across the four studies which evaluated preoperative CEUS
guided SLN biopsy, pooled sensitivity for identification of nodal
metastases was 54% (95% CI: 47 - 61) and pooled specificity 100%
(CI: 99 - 100).
Conclusion
CEUS is a promising technique for pre-operative staging of the axilla.
CEUS guided core biopsy has the potential to identify nodal metasta-
ses in over half (54%) of patients with normal axillary B-mode ultra-
sound. CEUS guided identification and localization of the SLN may
offer a viable alternative to standard lymphatic mapping using iso-
tope and blue dye, however, further prospective studies with larger
samples are warranted.
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Accurate assessment of axillary nodes in patients with breast cancer
influences MDT recommendations about primary therapy, axillary
surgery and additional investigations. Ultrasound with image-guided
needle biopsy of abnormal nodes is recommended by NICE and cited
in the DoH Best Practice Guidelines. Does improved sensitivity of axil-
lary imaging increase the rate of referral for staging investigations?
A completed audit loop evaluated the sensitivity and PPV of axillary
ultrasound and image-guided node sampling in consecutive primary
breast cancer cases in 2014 and 2012 at the breast imaging unit of a
large teaching hospital. Results were compared with published data
and the impact on rate of preoperative CT staging and detection of
distant metastatic disease was assessed.
Between 2012 (n=47) and 2014 (n=270) overall sensitivity of axillary
ultrasound for metastatic nodes increased from 20% to 38%,
achieving 95% sensitivity for patients with >1 abnormal node on
ultrasound and 61% sensitivity for those with >2 positive nodes at
surgery. Between the two audits PPV increased from 40% to 68%
and the number of needle biopsies performed significantly in-
creased, yielding a sensitivity of 79% (22/28) in 2014. Referral for
pre-treatment staging CT also increased with positivity rate for dis-
tant metastases decreasing from 17% to 11% (7/65).
Significantly improved sensitivity and PPV of axillary node ultrasound
and needle biopsy are attributed to raised awareness of published
data and MDT expectations and feedback. This has resulted in in-
creased referral for pre-operative staging CT with a concomitant de-
crease in rate of detection of distant metastatic disease.
PB.4
Axillary scanning at a District General Hospital (DGH) symptomatic
breast clinic (SBC) - Audit and review
Srikanth Puttagunta, Karen Gray
Hairmyres Hospital, Lanarkshire, UK
Correspondence: Srikanth Puttagunta
Breast Cancer Research 2016, 18(Suppl 1):PB.4
Introduction
Preoperative Ultrasound (US) assessment of axillary nodes is crucial
in tailoring management of breast lesions and saves costs and time.
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from 54.1 % to 68.2%.
At this DGH, cut offs for abnormal axillary lymph nodes were frankly
abnormal features or a cortical thickness of 2.5mm or greater.
This audit/review assessed axillary scanning in the context of biop-
sied suspicious breast lesions at a DGH SBC.
Methods
The DGH SBC collects a list of all biopsy cases. Data was obtained
using this list, RIS and clinical portal for the time period 1 January
2015- 1 December 2015.
The following standard was utilised and assessed - “Ultrasound should
identify nodes with metastatic involvement with 50% sensitivity (RCR).”
The percentage of breast biopsy cases that also received US axilla
assessment at the same time and agreement between axillary US/
Biopsy and histopathology were also reviewed.
Results
 179 patients after exclusions with 93 cancer cases.
 Target result: US sensitivity = 63 .2 % (RCR target > 50%
sensitivity)
 96.8% of all malignant cases had their axilla scanned at initial
presentation
 79.5 % Agreement between US and histopathology
Conclusion
 This review suggests appropriate scanning of the axilla at this
DGH SBC.
 Regular assessment of sensitivity and frequency of axillary
scanning still recommended.
 Recommended local improvement of focusing towards
performing US in all microcalcification cases- to look for an
invasive focus for US biopsy (rather than stereotactic) with
axillary scanning at the same time.PB.5
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Background
The role of axillary node clearance (ANC) in patients with 1 or 2 posi-
tive sentinel nodes is being questioned in the POSNOC trial. Increas-
ing sensitivity of axillary ultrasound has resulted in identifying
preoperatively more lymph node positive patients and thereby fewer
differences with sentinel node positive patients.
The aim of this study was to determine if the number of abnormal
nodes seen on preoperative axillary ultrasound correlates with the
axillary tumour burden on histopathology after ANC, and whether this
information can be used to identify patients with low volume disease
who may be offered sentinel node biopsy(SNB) rather than ANC.
Methods
66 patients with FNA or core biopsy proven axillary nodal metastasis
were included in this prospective study from 4 centres. The number
of abnormal nodes at pre-operative ultrasound examination was
recorded (score of ≥3). All patients underwent ANC.
Results
31 patients had 1 abnormal node and 35 patients ≥2 abnormal
nodes on ultrasound scan. The median number of positive nodes
found on pathology was 2(range 1-9) in patients with 1 abnormal
node and 5(range 1-33) in patients with ≥2 abnormal nodes
(p<.0001). 20 of 31 patients(64.5%) with 1 abnormal node onultrasound had ≤3 positive nodes at ANC. 18 of 31 patients(58.1%)
with 1 abnormal node had only 1 or 2 positive nodes at ANC.
Conclusion
Patients with 1 abnormal node seen on ultrasound can be offered
SNB rather than ANC as the initial axillary surgery avoiding overtreat-
ment and unnecessary arm morbidity in a significant number of
patients.
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Introduction
Identifying axillary lymph node metastases preoperatively can inform
discussions about neoadjuvant chemotherapy and also allow a pa-
tient to proceed to an axillary lymph node dissection (thus avoiding
an additional sentinel node biopsy procedure).
A meta-analysis has not shown a statistically significant difference in
sensitivity between axillary US-guided fine needle aspiration biopsy
(FNA) and core needle biopsy (CNB)1. Moreover, previous studies on
this subject have only included low numbers of patients. Our aim
was to directly compare the sensitivity of the two techniques.
Method
Patients with macrometastic nodal involvement treated at a tertiary
referral centre between January 2012 and December 2015 were
retrospectively identified from pathology records. The preoperative
(first attempt) FNA and CNB results were compared to post-operative
histopathology results.
Results
A total of 114 CNB's and 229 FNA's were performed. There were 87
true positive CNB's and 147 true positive FNA's. US-guided CNB was
therefore more sensitive than US-guided FNA (76.3% vs. 64.2%, p =
<0.05). There were 9 inadequate results in the CNB group and 16 in
the FNA group (7.9% and 7.0%, respectively).A single haematoma re-
quiring non-operative management was recorded in the CNB group.
Conclusion
US-guided CNB of the axilla is more sensitive than US-guided FNA
and is a safe technique in experienced hands.
References
1. Houssami N, Ciatto S, Turner RM, Cody HS, Macaskill P. Preoperative
ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer:
meta-analysis of its accuracy and utility in staging the axilla. Ann Surg
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PB.7
Potential impact of implementing new ABS guidelines for
management of patients with Axillary nodal metastasis on Sentinel
Lymph Node biopsy
Sophie Greenhalgh2, Muthyala Sreenivas1
1University Hospitals of Coventry and Warwickshire, Coventry, UK;
2Warwick Medical School, Coventry, UK
Correspondence: Sophie Greenhalgh
Breast Cancer Research 2016, 18(Suppl 1):PB.7
Background
In the era of the ACOSOG Z0011 trial, omission of Axillary Lymph
Node Clearance (ALNC) in patients with low volume nodal disease
and good prognosis cancer is becoming the norm. The Association
of Breast Surgeons (ABS) recently produced guidance on axillary
management which partially mimic Z0011. The impact of guidance
implementation is yet unknown.
Method
Patients with newly diagnosed invasive breast cancer, with macrome-
tastasis in 1-2 sentinel nodes plus follow up ALNC, during 2012-2014 at
Breast Cancer Research 2016, 18(Suppl 1):107 Page 5 of 20UHCW were selected retrospectively. Inclusion criteria as per ABS guide-
lines creating 2 patient groups: Good prognosis and bad prognosis
cancers. Patients were then grouped into 1-2 or 3 or more nodes based
on their total lymph node metastasis burden after ALNC to determine
adequacy of proposed treatment. Data was analysed in excel.
Results
484 patients underwent Sentinel lymph node biopsy, of which 96
had macrometastasis in 1-2 nodes. 18 patients met the criteria for
good prognosis and of these 15 (83.3%) had a total axillary node bur-
den of 1-2 nodes. Only 3 (16.7%) patients had a total of 3 or more
positive nodes after ALNC. However, 63 patients met the criteria for
bad prognosis, of which only 18 (28.6%) had 3 or more positive
nodes after ALNC, the remaining 45 (71.4%) only had a total burden
of 1-2 nodes.
Conclusion
Implementation of ABS guidelines would have resulted in 16.6% of
good prognosis cancers to be undertreated whilst 71.4% of bad
prognosis cancers would be over-treated with unnecessary axillary
surgery and its resultant morbidity.PB.8
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Background
In the era of Z0011, current practice of axillary node clearance for pre-
operative US detected lymph node metastasis will result in overtreat-
ment of the axilla as some of these patients only have 1-2 positive
nodes.
Methods
Patients with lymph node positive, newly diagnosed invasive breast
cancer, during 2012-2014 at UHCW were selected retrospectively. Ab-
normal nodes defined by local criteria underwent ultrasound-guided
FNA or core biopsy. Patients were grouped into 1-2 or 3 or more
nodes (3+) based on their lymph node metastasis burden after ALNC,
and tumour characteristics compared. Categorical variables were
evaluated with chi-squared and Fisher’s exact tests.
Results
556 patients were diagnosed with invasive cancer, of which 210 had
lymph node metastasis. 64 patients were found preoperatively
(30.5%) and progressed to ALNC. However, 20 patients (31.3%) had
only 1-2 positive nodes. Significantly more in the 1-2 node group
underwent breast conserving surgery compared with the 3+ group,
65% versus 25% (p=0.002), and less had T3 cancers, 0% vs 22%,
(p=0.024). The 1-2 node group also had a lower proportion of
lymphovascular invasion (15% vs. 25%), lobular (10% vs 18%) and
grade 3 cancers (20% vs 34.1%) albeit not significant. ER status (80%
vs 79.6%) and postmenopausal age (90% vs 88.6%) were similar.
Conclusion
Axilla management of patients with pre-operatively diagnosed lymph
node metastasis currently leads to overtreatment in 31.3%. There is
scope to identify patients with a low nodal burden to select them for
axillary staging and possibly avoid ALNC.PB.9
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Axillary Lymph Node clearance (ALNC) is avoidable in patients with
low volume nodal disease. Nomograms from MSK and MD Anderson
Cancer Centres (MSKCC and MDA) and Helsinki Hospital are promis-
ing predictors of additional node metastasis after Sentinel lymph
node biopsy (SNB) but their clinical utility is undetermined.
Method
Invasive breast cancer patients newly diagnosed during 2012-2014 at
UHCW, with macrometastasis in 1-2 sentinel nodes and ALNC were
selected retrospectively. Inclusion criteria: clinically node negative
(cN0) and pT1-T2 cancers. Risk scores were calculated using MSKCC,
MDA2 and Helsinki nomograms. Patients were grouped based on
total nodal burden after ALNC: 1-2 and 3 or more (3+) nodes. Scores
between groups were compared with non-parametric independent-
sample Mann-Whitney tests. Nomogram utility was evaluated with
area under the ROC curve (AUC) analysis.
Results
144 patients had a positive SNB, of which 95 patients had cN0, pT1-
T2 cancer with macrometastasis in 1-2 nodes. 72 patients (75.8%)
had a total 1-2 nodes and 23 patients (24.2%) had 3+ nodes after
ALNC. All nomograms were significantly distinguished between
patient groups (MDA2 p=0.032, MSKCC p=0.001, Helsinki p=0.030)
and AUC gave values and 95% confidence intervals of 0.649 [0.523,
0.775], 0.729 [0.615, 0.843] and 0.651 [0.527, 0.775] for MDA2, MSKCC
and Helsinki respectively.
Conclusion
Overtreatment with ALNC is 75.8% in patients with sentinel node
macrometastasis in 1-2 nodes. MSKCC nomogram had the best utility
to identify this group with AUC 0.729. MDA2 and Helsinki nomograms
also had good clinical use in deciding which patients should receive
axillary clearance.PB.10
Is MRI necessary in patients with invasive lobular carcinoma and
fatty breasts?
Anju Nandhra, Sheetal Sharma
Queen Elizabeth Hospital Gateshead, Gateshead, UK
Correspondence: Anju Nandhra
Breast Cancer Research 2016, 18(Suppl 1):PB.10
Introduction
Invasive lobular cancer (ILC) attributes to 5-10% of new breast cancer
diagnosis. It is often mammographically occult with detection rates
of 57-87%. Fibroglandular tissue density is inversely correlated to
mammographic detection rates and there is also an increased rate of
multifocality in ILC. MRI has higher detection rates of 93% and is
recommended in patients with ILC. Theoretically mammographic ILC
detection should be better in fatty breasts and therefore we ask
whether MRI essential in this subgroup of patients?
Aim
To ascertain if MRI detects any significant additional lesions in pa-
tients with ILC and fatty breasts.
Methods
Retrospective study of breast MRIs conducted within a 4 year period
for histological confirmed ILC. Breast densities of 1 were included. All
imaging reports recorded.
Results
134 patients identified with ILC, 103 excluded as had breast density
2 or more. 31 identified as having breast density of 1. Primary lesion
identified on mammography in 28 patients and on ultrasound in 3
patients. MRI identified additional findings in 9 patients which were
occult on mammography. Of these 9 cases, 3 were identified as add-
itional cancers and the remaining 6 were benign.
Conclusion
MRI detected 3 additional cancers which were otherwise occult on
mammogram despite the patient having fatty breasts. These results
are congruent with published literature. A study published in 2012
identified 7 additional cancers in 32 cases. We therefore conclude
that MRI is necessary in imaging patients with ILC and low density
breast tissue on mammography.
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Introduction
Neoadjuvant chemotherapy is a well-established method of treating
large breast carcinomas with the aim of shrinking the tumour to en-
able breast conservation surgery or to improve outcomes of treat-
ment for patients requiring mastectomy by delivering early systemic
therapy to reduce the risk of metastatic disease.
In many institutions, MRI scans are performed prior to the com-
mencement of neoadjuvant chemotherapy, at the mid-point of treat-
ment and at the end of chemotherapy prior to surgery. The aim of
this audit was to assess the benefit of performing the final MRI scan
in the patient's surgical management.
Methods
A list of relevant patients undergoing neoadjuvant chemotherapy
was obtained from a database maintained by the breast care nurses.
Tumour size on the final MRI scan was compared with tumour size
determined histologically from the operative specimen, which was
regarded as the gold standard for the purposes of this audit. Con-
cordance was regarded as satisfactory if the tumour size was within
10mm on radiology and histology.
Results
There was 77% concordance between the final MRI scan and the
postoperative histology. However the findings at MRI did not alter
the surgical management decision and in patients where there was
discordance in tumour size between imaging and histology, none re-
quired further surgery.
Conclusions
Although felt to be useful by some surgeons and oncologists, MRI
scans post neoadjuvant chemotherapy prior to surgery can be safely
omitted without adversely affecting the patient's management.PB.13
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Aim
To evaluate additional findings on patients undergoing breast MRI
for pre-operative planning.
Methods
Our unit conducted 73 breast MRI studies between 30/06/2015 and
30/06/2016. These were performed for various indications; multifocal-
ity, disease extent in lobular carcinomas, mammographically occult
cancers, young patients with breast cancer and dense breast tissue.
Age ranged from 31-70 years. Histology was correlated for all positive
findings.
Results
Total of 27% scans had relevant findings which required further in-
vestigations. Benign lesions contributed 20% to the relevant findings,
5% of these required change in management.
Sinister findings were depicted in 80% of all the relevant findings.
Metastases contributed 30% to the relevant findings. In terms of dis-
ease extent or localisation identified with high clinical suspicion and
negative imaging, 20% had mammographically occult carcinomas,
multifocal disease was present in 20%, 1/20 had diffuse disease and
1/20 was positive for contralateral carcinoma.
In summary, management was changed in 23.2% of all the scans.Conclusion
Breast MRI does demonstrate significant additional lesions. Though
these warrant further imaging, patient management and MDM
recommendation may alter which is proven in 23.2% of cases in our
study.PB.14
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Background
Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI)
is used to monitor tumour response to neoadjuvant chemotherapy
(NAC) for locally advanced breast cancer (LABC) through analysis of
tumour morphology (size and shape) and contrast kinetic patterns.
This study aimed to identify pre-NAC MRI and tumour features which
could help predict response to NAC. We also investigated the ability
of post-NAC MRI to accurately represent the extent of any residual
disease which is of importance for surgical planning.
Methods
This retrospective cohort study evaluated forty-six patients with LABC
who received NAC between 2008 and 2016 at UHCW. All patients
underwent pre and post-NAC DCE-MRI and proceeded to surgical
excision. Clinical and imaging data was collected from CRRS and
UHCW PACS.
Results
Several tumour features were found to be predictive of pathological
response, including: tumour morphology, oedema, shrinkage pattern,
HR status, HER2 status and percentage change in MRI long diameter.
Circumscribed lesions were more likely respond to NAC than irregu-
lar, diffuse and nodular tumours. There was some evidence of correl-
ation between MRI morphological categories and tumour receptor
status. The accuracy of post-NAC MRI for predicting residual disease
was superior for HR negative tumours.
Conclusions
Pre-treatment MRI features can serve as reliable imaging bio-
markers which can be used to predict disease response to NAC.
The accuracy of post-NAC MRI varies with tumour biology and im-
aging features, and this should be considered in decisions about
surgical approach.PB.15
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Introduction
Tumour size assessment with imaging has an impact on the diagno-
sis and treatment planning of breast malignancy. We assessed the
correlation between preoperative size of lobular breast cancer on dif-
ferent imaging modalities and postoperative histological size, as the
reference standard.
Methods
Retrospective review of lesion size on digital mammography (DM),
ultrasound (US) and contrast-enhanced MRI from 73 breast lesions
was performed in 63 consecutive women with histological diagnosis
of lobular breast cancer. The sizes of different modalities were corre-
lated with histological tumour size using paired T-test analysis and
coefficient of determination.
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Of the 63 women included, 3 (5%) had bilateral lesions and 7 (11%)
had 2 foci in the same breast; 73 separate lesions were entered in
the analysis.
The mean tumour sizes were: histological = 21 mm (SD = +/- 16mm),
DM = 19 mm (SD = +/-15mm), US = 14mm (SD = +/- 12mm), MRI =
20 mm (SD = +/- 16mm).
The means of imaging modality minus the histology size were: MRI
-0.85 (95%CI: -2.87 to 1.17, p-value= 0.4042), DM -1.77 (95%CI: -4.43 to
0.89, p-value= 0.1895) and US -6.77 (95%CI: -9.06 to -4.47, p-value= 0.
0.0001).
When compared to histology, coefficients of determination (R-squared)
were: MRI 0.72, US 0.62 and DM 0.53.
Conclusion
There is no statistically significant size difference between MRI and
histological size. Furthermore, correlation between the two is high. In
comparison with DR and US, MRI is a reliable imaging modality in
preoperative assessment of lobular breast cancer size.
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Introduction
MRI is under scrutiny and the new NICE guidance states that all breast
cancers should not have an MRI unless clear indication. We reviewed
our practice as an experienced unit.
Methods
All cases where MRI performed to plan surgery were identified in the
calendar year 2014. Type and number of operations and whether 2nd
look ultrasound performed noted.
Results
Approximately 600 breast cancers per year (symptomatic/screening).
103 Breast MRI's (17% total cancers).
13 cases excluded as no surgery/NACT/incomplete information.
Total 90 cases, 35 for extent of lobular, 46 other reasons - size mis-
match/? MF/MC/mammo occult/dense mammogram and 9 for high
grade DCIS.
72/90(80%) went straight to surgery - 51(71%) WLE, (45 single oper-
ation) and 21(29%) Mastectomy.
18/90(20%) had a 2nd look Ultrasound and 14/18 had biopsies(10
US, 3 MRI, 1 Diagnostic). 9/14 malignant and 5/14 benign.
Of the 9 malignant biopsies, 8 in the ipsilateral and 1contralateral
breast.
Of those who went to Mastectomy 7 had 2nd look Ultrasound and
biopsy (1 contralateral breast) and 2 had 2nd look ultrasound and no
biopsy.
Conclusion
17% of our cases had MRI showing that we are adhering to the NICE
standard. In 60% of cases MRI allowed for successful single conserva-
tive operation. MRI allows picturisation of tumour morphology e.g. 2
discrete lesions or 2 lesions with extensive disease between them,
aiding appropriate surgery. MRI needs to be reported by expert
breast radiologists and interpreted within the clinical context by the
MDT team.
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Aim
Both performing and reporting breast MRI scans is time consuming
and expensive. An alternate method for imaging and reporting
which achieved excellent results utilising a shortened protocol andrapid reporting was reported by C. Khul et al. This retrospective study
was used to test the feasibility of such protocol in a centre which is
starting to perform high risk breast MRI screening.
Methods
Three consultant radiologists (C1, C2 and C3 with 7 to 9 years of experi-
ence in reading breast MRI) retrospectively and independently
reviewed 27 high risk breast MRI studies. All cases were annonymised
and review was only performed as per C. Khul's paper, that is MIP im-
ages and abbreviated protocol images consisting of pre-contrast, first
post-contrast and its subtracted counterpart were only reviewed and
reported. Time taken for MIP and abbreviated protocol reading and the
sensitivity and specificity for both were calculated for each reader.
Results
Average time to read MIP and abbreviated protocol images were: C1
= 1.8 and 26.3 sec, C2 = 2.6 and 8.1 sec and C3 = 5.3 and 63.7 sec.
Only one patient had cancer (bilateral cancer) and imaging finding
were scored R3 and R4 for right and R5 for left by all readers. There-
fore, no cancer was missed. Altogether 7 cases underwent 2nd look
US and found to have benign results.
Conclusion
This small study shows that the method reported by C. Khul is feas-
ible and should result in lower cost service. Prospective larger scale
UK study should be considered.
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Introduction
There is a lack of collated data on the appearance of cancers in digital
mammograms. This information may help in understanding which le-
sions appearing in mammograms are potentially fatal and which low risk.
Methods
Mammograms have been collected since March 2011 from three breast
screening sites alongside the clinical information from National Breast
Screening Service (NBSS). Experienced readers have marked a rectangu-
lar region of interest (ROI) closely around identified cancers and classi-
fied each cancer's conspicuity and appearance. The cancers size was
calculated as maximum dimension (height or width) of the ROI. The
data were analysed to investigate the appearance of the cancers.
Results
Currently, there are 4657 women's images in the database with inva-
sive and in-situ cancers. 3400 of the cancers have been marked with
complete data. Most of the cancers were described with an obvious
conspicuity (67%) rather than subtle or very subtle. It was found that
10%, 22%, 21%, and 47% of the cancers were in the following mam-
mographic size ranges ≤10mm, 10-15mm, 15-20mm, >20mm re-
spectively. The most common cancer appearance was masses (50%),
followed by calcification clusters (28%), asymmetric densities (13%)
and architectural distortions (9%). The masses were classified as ill-
defined (58%), spiculated (38%) and well defined (4%), also 14% of
them had associated calcifications.
Conclusion
We have characterised the appearance of a large set of cancers.
Once the database is fully linked to data in NBSS, then cancer grade
and biology can be included in the analysis.
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There is evidence that digital mammography improves breast cancer
and non-invasive detection rates when compared to analogue. This
has been the case as breast units across the country have changed
over to digital equipment. Does replacement of older digital for new
digital equipment further increase cancer detection rates?
Method
The North and East Devon Breast Screening unit run by InHealth was
the first unit in the country to become fully digital in2006. Thus we
will have been the first unit to replace all our digital equipment for
new, carried out in 2013. We have reviewed cancer rates for the final
year with old digital equipment and the 2 years post replacement.
Results
We have shown an increase in cancer detection rates following replace-
ment of digital equipment. Non-invasive detection rate per 1000
screened has increased from 1.68 to 2.55 and 2.25. Small invasive can-
cer rate has increased from 2.66 to 2.81 and 3.12. Tables document
these results for invasive, non-invasive and <15mm cancers for preva-
lent and incident groups over 3 years.
Conclusion
Replacement of digital mammography equipment for new increases
cancer detection rates particularly in non-invasive and small cancers.
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Introduction
Mammography has been variously reported as both overestimating
and overestimating the size of breast cancer when compared to hist-
ology. This study aimed to determine whether the inclusion of spicules
when measuring the cancer reduces the discordance between the two
methods.
Methods
Data from 91 patients with either invasive ductal carcinoma (IDC) or
invasive lobular carcinoma (ILC) were analysed in a retrospective
study from January 2014 to March 2016. Histological tumour size was
assessed with and without ductal carcinoma in situ (DCIS) for the
overall tumour size and similarly mammographic size was measured
with and without spicules. The largest tumour diameter was chosen
in each case. Correlation was assessed using Spearman's rho. A
Bland-Altman analysis was used to assess the agreement between
the mammographic and histological sizing techniques.
Results
76 patients had IDC and 15 patients had ILC. The mean difference
between IDC + DCIS histology and mammographic with spicule was
-5.7mm (+/-10.6mm), r = 0.72. The mean difference between IDC +
DCIS histology and mammographic without spicule was 4.2mm
(+/-10.9mm), r = 0.68. The mean difference between ILC histology and
mammographic with spicule was -7.9mm (+/- 10.0mm), r = 0.73. The
mean difference between ILC histology and mammographic without
spicule was 3.1mm (+/-5.7mm), r = 0.82. A Bland-Altman analysis
revealed only ILC without DCIS histology and mammography without
including spicules had good agreement.
Conclusion
The inclusion of mammographic spicules over estimates the final
histology size for both IDC and ILC without improving the correlation
between the two methods.PB.23
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Introduction
Full field digital mammography (FFDM) is currently the gold-standard
breast imaging modality for suspected breast cancer, however it has
limitations imaging dense breasts. Contrast enhanced spectral mam-
mography (CESM) is a new technique which utilises dual energy expo-
sures with iodinated contrast media to highlight areas of angiogenesis,
a characteristic of malignancy, on mammography images. This could
improve the diagnostic accuracy of mammography.
Objectives
Undertake a systematic review comparing CESM with FFDM, to es-
tablish whether sensitivity and specificity of breast cancer detection
is significantly improved.
Methods
A comprehensive search of journal databases and grey literature
sources was performed using multiple terms for CESM, FFDM and
breast cancer to identify relevant literature. These studies were
screened against pre-determined inclusion and exclusion criteria to
ensure they were applicable to the review question. The included
studies were quality assessed and their data extracted.
Results
Eleven relevant studies were identified. These performed the same
CESM technology (G.E. SenoBright®) and varied mammography tech-
nologies on the same patients with either newly diagnosed breast
cancer or suspicious imaging. All studies showed CESM increased
sensitivity by 3.1-21.2% and 10 studies showed increased specificity
by 5-45.7% (one study found specificity decreased by 4%) compared
to mammography. However the differences were not always signifi-
cant, the data was heterogeneous, and none of the included studies
fully demonstrated low risk of bias when quality assessed.
Conclusion
CESM may improve sensitivity and specificity of breast cancer detection
compared to mammography. However further research is required to
establish applications and determine which patients would benefit.
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Introduction
To analyse the pattern of parenchymal tissue on mammography in
women with the densest breasts, variation with age and the effect
on recall rates and cancer detection.
Methods
Breast density data (VolparaTM) was obtained in women attending
mammographic screening between April 2013 and March 2015. Cases
with the densest breasts were selected for visual interpretation of
parenchymal pattern. 100 cases were included for non-assessed
women age 50, 55, 60, 65 and 69-71. All cases of assessed women with
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10 film readers. Parenchymal pattern was classified as: smooth; mainly
smooth, mixed; mainly nodular or nodular.
Average classification was compared by age and assessed v non-
assessed. Likelihood of biopsy and cancer diagnosis was analysed by
parenchymal pattern.
Results
40760 women were included in the subset, 4331 (10.6%) of these
were Volpara4. Proportions in each parenchymal pattern category
were similar at all ages and for assessed v non-assessed.
In the assessed group 90 were smooth/mainly smooth; 104 mixed;
106 mainly nodular/nodular. Of women who were subjected to bi-
opsy, 50 were smooth/mainly smooth; 57 mixed; 56 mainly nodular/
nodular. Of women diagnosed with cancer, 7 were smooth/mainly
smooth; 10 mixed; 18 mainly nodular/nodular. More cancers were
identified in women with nodular breasts.
Conclusion
The ratio of smooth to nodular pattern in women with the densest
breasts did not vary with age. The parenchymal pattern of breast tis-
sue did not affect recall rate, but women with nodular breasts were
more likely to be diagnosed with cancer.PB.25
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Introduction
Approximately 10% of symptomatic female breast cancers (BC) are
mammographically occult (MO) yet data is scarce regarding presenta-
tion and histology of the primary and any recurrence. It is unknown
whether mammographic follow-up is appropriate. We are auditing
women diagnosed with symptomatic MOBC across 3 UK centres, to in-
crease the knowledge base and inform future surveillance methods.
We present preliminary results.
Method
For each centre women ≥ 35 attending as GP referred between 2006
and 2010, undergoing mammograms and diagnosed with a symp-
tomatic MOBC were retrospectively identified. Presentation, histology
and treatment data was collected. Type/frequency of imaging follow-
up and subsequent recurrences to 31.12.15 were documented. Each
MOBC identified was age matched with 2 women with a mammog-
raphy visible cancer.
Results
116 MOBC were identified across 2 centres (332 controls), average
age 53yrs. 76.5% presented with a lump vs 81.6% in the control
group. 37.3% vs 17.5% had very dense parenchyma. Mean size at
diagnosis was 15.5mm (range 4-37) vs 24.0mm (range 4-90). 11.1%
vs 9% were lobular. 62.6% vs 51% were node negative 91.1% vs
90.3% were ER+ve and 11.2% vs 20% were HER 2+ve. 52.4% vs
33.4% underwent breast conservation. Mammographic follow up was
similar for each group; median 5.4yrs (range 0.4-9.9). All 6 recurrences
to date were visible on mammography.
Conclusion
Preliminary data suggests that MOSCs are more common in dense
breasts, but smaller at diagnosis favouring surgical conservation. Recur-
rences are not necessarily occult so mammographic follow-up may be
appropriate. Further data is being collated to consolidate findings.PB.26
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Introduction
Mammographic density (MD) is the strongest modifiable risk factor
for breast cancer. We studied MD changes over a 3-year period and
the effect BMI, menopausal status and HRT had.
Methods
Recruitment included 5751 women who participated in the Predict-
ing Risk of Cancer At Screening (PROCAS) study and had a second
routine screen. BMI, menopausal status and HRT use were self-
reported at first PROCAS screen. Fibroglandular volume (FGV, an ab-
solute measure for MD) was measured using an automated volumet-
ric method (VolparaTM) at both screens.
Results
Average starting FGV was 49.951 cm3 and decreased 0.474 cm3 over
the 3-year period. However, 48.7% of women demonstrated an increase
in FGV. Women with normal BMI gained on average 0.557 cm3 in FGV.
As BMI increased the average FGV decreased with obese women losing
on average 2.256 cm3. Women who were pre/perimenopausal at first
screening had larger drops in FGV than postmenopausal women.
Within postmenopausal women 49.4% saw rises in FGV and of those
who did the average gain was 8.562 cm3. The use of HRT showed an
expected positive correlation with FGV.
Conclusion
There was an overall decrease in MD over the 3-year period. How-
ever, 48.7% of women demonstrated an increase in MD; in particular
women with normal BMI, postmenopausal women and women on
HRT. These data show that to fully understand changes in individual
MD for both breast cancer risk prediction and risk reducing interven-
tions, confounding factors must be taken into account.PB.27
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Introduction
Breast screening in the UK is undergoing many workforce changes as
more experienced radiologists retire and new readers become en-
gaged. With such major changes it is important to monitor mammo-
graphic interpretation skills for national quality assurance purposes.
A detailed analysis has been carried out to compare the performance
of ‘newcomers’ to the national performance measures on the PER-
FORMS scheme of more experienced readers.
Methods
All UK screening readers take part annually in the PERFORMs educa-
tional scheme. 59 new participants read a recent set of PERFORMS
cases. Nationally, 726 more experienced readers also read the diffi-
cult same cases.
Results
A two-tailed t-test indicated that the mean of cancer detection of
new participants was significantly lower as compared to the national
average of more experienced participants (p<0.0001, Mnew=72.35%
Mnational=85.82%). The correct recall (sensitivity) of the new participants
was also significantly lower than the national average (p<.000001,
Mnew=72.88%, Mnational=85.92%). Additionally, the correct return to
Breast Cancer Research 2016, 18(Suppl 1):107 Page 10 of 20screening (specificity) of the new participants was significantly lower
than the national average (p<.000001, Mnew=85.86%, Mnational=83.55%).
Conclusions
On several performance measures, new breast screening readers per-
formed significantly worse than more experienced readers. This may
partly be due to them being new to taking part in the PERFORMS
scheme but that cannot fully explain the very significant differences
found. The purpose for the PERFORMS scheme is to highlight such
performance differences and to then help new, and poor performers,
improve and maintain their performance so that the quality of the
National Screening Programme remains high despite workforce
changes.PB.28
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Introduction
CESM produces low and high energy images at specific time intervals
taken once a patient has been injected with an IV contrast agent. In
the post processing phase the two images are recombined producing
an image in which contrast enhancement is visible. Studies show it to
be as sensitive as MRI in detecting uni and multi focal disease, poten-
tially providing an alternative to MRI for specific patient groups.
Methods
A single centre matched study comparing the sensitivity and specifi-
city of CESM with breast MRI of patients who had both CESM and MRI
performed within the trust was conducted. Images were reviewed and
the following data extracted:
Number of lesions
Lesion size
Histology results - grading and size
Data was analysed; sensitivity, specificity, PPV and NPV of CESM
verses MRI were calculated.
Results
A total of 31 women participated in the study.
Results show that CESM had a sensitivity of 97% (36/37) and a speci-
ficity of 60% (3/5) with a PPV of 94% (36/38) and a NPV of 75% (4/5).
MRI had a sensitivity of 100% (38/38) and a specificity of 75% (3/4)
with a PPV of 97% and a NPV of 100%.
Conclusion
Results show the sensitivity and specificity of CESM is similar to that
of MRI. Preliminary findings show, in specific cases CESM could be
used as an alternative to MRI in lesion detection. As this is a small
sample size, further analyses of future data should be performed to
see if changes to practice can be implemented.PB.29
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Introduction
There is ongoing concern that silicone implants, particularly those
placed in a subglandular position, may reduce the sensitivity of
mammography in the detection of malignant lesions. Our aim was to
determine whether or not breast implants affected the cancer detec-
tion rate in our screening population.
Methods
A retrospective search was undertaken to identify all patients with
breast implants who had been diagnosed with breast malignancy,
through the West of Scotland Breast Screening Programme
(WOSBSP), over a period from April 2010 - March 2015. The numberof malignancies was then compared with the number detected in
the non-implant population during the same time period.
Results
During the period, 310,558 patients attended for screening. Of these,
852 had breast implants.
A total of 2,840 malignancies were detected, 6 of which were in pa-
tients with implants - 1 prevalent and 5 incident. All 6 had subglandular
implants. There were 3 diagnoses of DCIS and 3 of invasive carcinoma,
with a size range of 10-34mm. None of the patients had nodal disease
at the time of diagnosis.
The malignancy detection rate in the implant group was 7 per 1000
and 9.2 per 1000 in the non-implant group (P=0.52).
Conclusion
Although there appears to be a trend towards a lower cancer detec-
tion rate in women with implants, the results do not reach statistical
significance.
However our study is limited by small numbers of cancers in women
with implants and this also precludes further analysis of data for inva-
sive and small cancer detection rates.
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Imaging of breast implants is increasingly performed to investigate
suspected leak or rupture. However, there is little opportunity for the
radiological findings to be correlated with the pathological findings,
providing feedback as to the accuracy of the radiological diagnosis.
We reviewed pathological findings in explanted breast implants, in
conjunction with the radiological findings, to investigate the accuracy
of imaging for breast implant changes.
The pathology database was searched for all breast implants removed
between July 2000 and January 2015. All patients identified had their
imaging history reviewed to identify those with pre-operative imaging.
Pathological findings at implant removal and radiological findings on
the pre-operative imaging were compared.
There were 106 implant related pathology cases identified. From this,
11 patients had explant of breast implants and pre-operative imaging.
In 8 cases implants had been placed for cosmetic augmentation, 3
were following implant-based reconstruction. 10 cases had pre opera-
tive ultrasound, 1 had MRI and 1 had both. Radiological findings dem-
onstrated intra or extra capsular rupture in 9, silicone granulomas in 1
and an intact implant in 1 case. Imaging findings were consistent with
the pathological findings in all cases.
Imaging of implants provides an accurate pre-operative assessment of
implant pathology. As many more implants are imaged than removed,
and many implants removed without any pre operative imaging, it is
difficult to get feedback about the accuracy of radiological diagno-
ses in this setting. Although small, this study shows 100% concord-
ance between radiological and pathological findings following the
pre-operative imaging of implant pathology.
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Introduction
Patient’s symptoms and clinical examination are useful but can be
non-specific for breast implant rupture. We wanted to determine in
our unit how the presenting clinical features correlated with implant
rupture diagnosed on MRI.
Methods
A CRIS search was done for patients who had breast implant proto-
cols performed at our unit from 15/07/2015 dating back to 12/12/
Breast Cancer Research 2016, 18(Suppl 1):107 Page 11 of 202013. Data was collected from CRIS and Clinical Portal on symptoms
and implants.




Implant information collected included age, filling (saline/silicon/
Becker), lumen (single/double), position (subglandular/subpectoral).
Results
Forty eight patients had MRI leading to assessment of 89 implants.
Sixteen implants were ruptured, in 14 patients. 14(87.5%) presented
with pain; 9 (56.3%) had category (B) symptoms; 5 (31.1%) had a lump.
Mean ruptured implant age was 16.9 years. Interestingly, these implants
were in situ >10 years apart from 4. One of these developed symptoms
after assault whilst the remainder were PIP implants. Once these were
excluded, mean age was 20.8 years.
All ruptured implants were silicon except for one saline implant.
Positive predictive values (PPVs) for rupture were 40% for pain, shape
25.7%, lump 31.3%, implant age >10 years 37%, single lumen 18.8%
and silicon 17.8%.
Conclusion
Pain and implant age >10 years have the highest PPVs for rupture at
40% and 37% respectively. Overall, however, no symptoms or implant
factors were specific for rupture.
It is less likely that an implant <10 years would be ruptured unless in
exceptional circumstances eg trauma/PIP.PB.32
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Annual high risk screening MRIs have been reported at the Jarvis
Breast Screening unit since January 2014. There are currently 182
patients on our database which include patients with BRCA 1 or 2
mutation and patients who have received mantle radiotherapy below
the age of 30.
In 2014: 17 patients were recalled for further assessment. In 2015: 23
patients were recalled. Four Consultant Radiologists who also report
symptomatic MRI's took part in double reading.
Following the introduction of this new service we felt it was import-
ant to review our practise. This was done in order to understand our
recall rates and review the findings at assessment including results of
ultrasound and MRI guided biopsies, cancer detection, early recall
and interval cancer rates. We include a pictorial review of examples
of the recalled lesions.PB.33
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Introduction
Since 2001, the Welsh breast cancer screening programme has offered
annual mammography to women below age 50, identified as having
an increased risk of the disease. Women are referred via the All Wales
Genetics Service who analyse client risk and apportion a risk category.
Women are screened from either aged 35 or 40 years accordingly. We
present results including cancer detection rate, numbers of screening
eposodes and try to determine whether this is cost effective.Method
A prospectively maintained NHSBSP equivalent database for women
with a significant family history of breast cancer was analysed retro-
spectively for uptake of screening and cancer detection, including
interval cancer episodes. The costs of this service were estimated.
Results
5586 moderate and high risk women have been invited for annual
screening. The average prevalent uptake was 82.4% and a total of
22270 mammograms were performed. 118 cancers were detected,
84 were screen detected and 34 were interval cancers. The cancer
detection rate in this moderate and high risk population combined
was 3.8/1000 screenings, which is significantly lower than 10/1000
seen in population screening (p<0.05). Cancer detection in these
moderate and high risk women was only a third of the general popula-
tion suggesting this screening technique is inappropriate and should
be abandoned for reasons of cost, stress and unnecessary radiation
exposure. We suggest that other screening methods, with further risk
stratification might be more effective.
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Lobular neoplasia in situ is classified as a B3 lesion of uncertain malig-
nant potential and confers an increased risk of concurrent and future
malignancy. In the absence of national guidance there is uncertainty
over optimal management and peak malignancy risk may not fall
within the 5 years of annual surveillance recommended by some
centres.
Biopsy reports from 1999-2015 at Southampton General Hospital
were screened for code B3 and/or diagnosis of LNIS with collection
of a comparison group of patients with B2 diagnoses. Recommended
management was noted and screening packets were reviewed to
identify subsequent assessments and biopsies.
LNIS was diagnosed in 130/12,141 breast biopsies (1.07%) performed
between 1999-2015 Concurrent malignancy was present in 44/130
(34.68%) of which 33/44 were infiltrative lobular cancer and a further
7/130 (0.05%) had a B4 or B5a diagnosis. Management of pure B3
lesions was highly varied in those with available follow-up data (58/
130) but most commonly comprised routine recall following surgical
excision biopsy (34.5%). Women with a B3 diagnosis of LNIS were at
increased risk of developing invasive malignancy compared to the
B2 group (8.62% and 3.13% respectively, p=0.21) and the average
time to malignancy was 15 years.
The high rate of concurrent malignancy, in particular invasive lobular
cancer, may support the theory that LCIS is a precursor lesion. LCIS
also confers an increased risk of subsequent invasive neoplasia which
in this study occurred on average 15 years from LCIS diagnosis. This
timeframe should be considered when recommending management
with enhanced mammographic surveillance.PB.35
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Aim
To investigate the changes in risk factor profile across time in Asian
women with breast cancer.
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321 Asian patients diagnosed with breast cancer at the Nightingale
Centre and Genesis Prevention Centre, University Hospital South
Manchester between 1999 to 2016 were divided into 6 year groups
according to their year of diagnosis. Established breast cancer risk
factors were analysed across the three groups to identify potential
changes and trends. Statistical analysis was performed across these
three groups primarily using analysis of variance (ANOVA) for
continuous variables and Pearson’s chi-squared tests for categorical
variables.
Results
There was a decreasing trend of proportion of patients with diabetes
mellitus (p<0.001). There were increasing trends for mean age of first
full term pregnancy, mean duration of interval between menarche
and first full term pregnancy, proportion of women who breastfeed,
and BMI. There was a decreasing trend of proportion of multiparous
women. However these findings were statistically insignificant.
Conclusions
There are changing trends in certain risk factors for breast cancer
which might contribute to the increasing incidence of breast cancer
in Asian women. More research has to be done on modifiable breast
cancer risk factors and how they can be altered to decrease breast
cancer risk.PB.36
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A survey of radiographer film reader's perceptions of workload, per-
formance and job satisfaction in the NHSBSP.
Introduction
Age extension has increased the film reading workload in breast
screening. A reported shortage of radiologists plus radiographers
double reporting also has the potential to increase reading volumes.
There is disagreement on whether performance declines with increas-
ing volumes. There are no recommendations on maximum reporting
volumes. This survey aims to identify themes which affect film readers’
perceptions of workload, performance and job satisfaction.
Methods
Purposeful sampling was used to select participants. All qualified radi-
ographer film readers were included. Electronic questionnaires were
distributed to managers to forward to participants. Thematic analysis
was used to analyse results.
Results
The overall response rate was 37%. 77% perceived an increased
workload. 60% report a sufficient workforce for reporting. 40% report
high volumes. Performance is thought to fluctuate following inter-
ruptions, PERFORMS and fatigue. 84% are satisfied in their role.
Conclusion
Radiographers are experiencing an increase in workload but report-
ing time is frequently interrupted. Audit should assess any effect on
performance by high volumes and visual fatigue. More time for
CPD is required and increased involvement in research and audit.
Job satisfaction is high amongst readers which should aid retention
and recruitment. With a potential future shortfall in radiologists, the
NHSBSP will be reliant on advanced and consultant practitioners to
maintain targets. There is the potential to further develop the role
but care should be taken not to compromise performance and job
satisfaction with the volume of work.PB.37
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Introduction
The NHSBSP KPIs require 90% of first offered appointment (FOA) and
first actual assessment (AA) to be within 21 days of screening mam-
mography. This leaves little flexibility for women unable to attend FOA.
Our unit consistently achieves FOA (monthly rates 93%-100% in last
round), but frequently breaches the AA (monthly rates 78%-100%). We
investigated why the breaches occur.
Methods
NBSS data were analysed for women recalled from screening for the
3 years spanning April 2013-March 2016.
Results
Of 3595 women recalled to assessment, 99.6% of FOA were within
the required timescale. Of these, 464 women were not able to make
their FOA. 113 women made an alternative appointment and
attended assessment within the 21 day limit; the remaining 351 did
not.
Overall, 377 (10.5%) of recalled women failed to have their AA within
21 days, with seasonal variation observed. In just 3.7% of all breaches
was the unit unable to make a FOA within 21 days. A further 5.0%
comprised a data entry error on NBSS, erroneously registering as a
breach.
Of the remaining breaches, 76.7% changed appointment at least
once; 14.6% failed to attend FOA (DNA) without contacting the unit;
1.1% had a DNA and made at least one other appointment change.
Reasons women changed appointments: inconvenient 55.0%; on
holiday 37.4%; unwell 3.1%; combination of these 4.5%.
Conclusion
Time to actual assessment frequently reflects client choice and/or cir-
cumstances. These factors are outside the control of the unit, making
the time to actual assessment a questionable measure of performance.
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Patients are advised to report any breast associated symptoms during
their screening mammograms in the Warwickshire, Solihull and Coven-
try Breast Screening Service (based at UHCW NHS trust). Although no
specific guidance on whom to recall exists, symptoms such as lump,
distortion/change in shape of breast, recent nipple discharge, eczema,
or recent inversion, skin tethering and dimpling are routinely recalled
for further assessment. In this retrospective study, we investigated the
types of symptoms reported and subsequent clinical, imaging and hist-
ology findings with specific aim of finding the number of cancers in
this cohort of patients.
Between 2011 -2015 data was collected from NBBS and hospital RIS,
PACS and CRRS on patients reporting symptoms during their routine
screening mammogram. This included 709 patients (age range: 47
to77 years, mean age of 56 years).
Subsequently, 15 patients were diagnosed with breast cancer, of these
3 patients were excluded as 2 of them were originally referred by the
radiographers who noticed the changes at the time of screening and
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mammography.
Among the remaining 12 patients, 6 had cancer on a site or side
completely different from the actual location of symptom patient
identified.
Therefore, 6 out of 709 patients (0.84%) who were recalled were con-
cordant with clinical symptoms.
This study shows the positive predictive value (PPV) of patients who
reported symptoms turning into a breast cancer is low. Therefore, an
alternate pathway of managing these patients should be investigated.
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Aim
To examine possible associations between regional disposable
household income and uptake of breast screening and investigate
whether any association is related to the type of invitation, catego-
rized as: first invitation; invitation to previous non-attender; invitation
to previous attender (last attendance <5 years); invitation to previous
attender (last attendance >5 years) and early recall invitation.
Methods
Data on breast screening uptake and Gross Disposable Household In-
come (GDHI) per head for the English regions for the years 1999-
2014 were obtained from the Health and Social Care Information
Centre and the Office for National Statistics respectively. Uptake data
were adjusted to fit calendar year and GDHI data were adjusted for
inflation. The association between these was assessed using multiple
linear regression.
Results
There was a significant (p<0.05) positive association between re-
gional GDHI per head and overall breast screening uptake with a co-
efficient of 0.00066 (95% confidence intervals 0.00027- 0.00106). This
is equivalent to a 0.66% rise in breast screening uptake for every
£1000 increase in regional GDHI per head. No type of invitation alone
showed a statistically significant association between GDHI per head
and breast screening uptake.
Conclusion
Regional disposable household income has a positive association
with uptake of breast screening in the English regions. In this study,
there was no significant association between GDHI per head and
breast screening uptake for any one type of invitation. Low income
populations should be targeted to reduce inequalities and further re-
search should determine which interventions can be cost effectively
applied to these populations.PB.41
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There is a current workforce crisis in breast radiology. This review
determines if double blind double reading continues to be necessary
as since the introduction of digital mammography individual cancer
detection rates have increased. Are single reader recalls contributing
to the detection of pathologically insignificant cancers.
Method
This is a retrospective analysis of prospectively collected data from the
NBSS database at BTW (S. E.). The readers had experience from trainee
to 20 years+. All single reader recalls that were assessed and diagnosed
as cancer were included from 2010-2015. Pathological data was col-
lected including size, tumour type, grade and node positivity. Data pre
and post digital screening mammography were evaluated.
Results
450 women were identified for analysis as single reader recalls. Of
the single reader recall cases, 317 were invasive and 131 non -inva-
sive. The majority (83.5%) of malignancies detected were TMN stage
1(Average size 14mm, mode 8mm, range 1-150mm). Of the invasive
malignancies identified, 103 were grade 1, 172 were grade 2 and 39
were grade 3 at final pathology. The total number of patients that
were node negative at subsequent surgery was 91.33%. 14.4% of all
cancers detected were attributed to a single reader recall. All readers
contribute to the single recall rate regardless of reader status.
Conclusion
Single reader recall detected cancers make up a significant proportion
of the cancers detected and are pathologically significant. It remains
important to continue with double blind reading despite workforce is-
sues and despite individually good cancer detection rates.PB.42
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Background
The South Asian population has increased across the UK along with
increase in breast cancer incidence in them. Yet the uptake rate for
breast screening in this group of women remains significantly lower.
Barriers to screening, such as language barriers can deter some
women from attending.
Materials and Methods
A pilot questionnaire study was carried out to assess the screening
experience of 110 women who watched a breast screening video on
a tablet device in their choice of language prior to screening. The
screening experience was assessed by a five item questionnaire. For
advanced understanding of the device and its related issues, supple-
mentary data was collected in the form of a radiographers’ feedback
questionnaire (n=92).
Results
The majority of the women participating were supportive towards
this method of help (85%) and had favourable opinion about the
device (90%). In total 93% of the women agreed that the video
helped them through the mammography procedure and 79.2%
agreed that it made their screening experience better. The radio-
graphers’ feedback suggested that time was a sensitive issue in
applying this method, with 39% suggesting it increased the clinic
times.
Conclusion
The usage of multilingual tablet device was perceived positively by the
majority of women attending for breast screening. It was considered
helpful in improving the individual’s screening experience and possibly
will have a positive impact on their compliance in subsequent screen-
ing rounds. The tablet device should be considered for national piloting
as part of the National Breast Screening Programme.
Breast Cancer Research 2016, 18(Suppl 1):107 Page 14 of 20PB.43
A review of MRI Guided Breast Interventions at the Royal Marsden
Hospital
Richard Sidebottom1,2, Elizabeth O’Flynn1, Laura Bombroffe1, Julie
Hughes1, Erica Scurr1, Robin Wilson1
1Royal Marsden NHS Foundation Trust, London, UK; 2Oxford University
Hospitals NHS Foundation Trust, Oxford, UK
Correspondence: Richard Sidebottom
Breast Cancer Research 2016, 18(Suppl 1):PB.43
Background
MRI guided breast biopsy is required to assess MRI abnormalities not
demonstrated on conventional imaging.
Methods
We performed a retrospective audit of all MRI guided breast inter-
ventions at the Royal Marsden from 2012, when the service began,
to 2015. Data was obtained the Electronic Patient Record and MRI re-
cords. MR imaging characteristics and histology were recorded along
with the types of referrals, technical aspects of the procedures and
complications.
Results
57 patients were booked for an MRI guided intervention (31 Royal
Marsden patients, 26 external referrals). The appointment for biopsy
was on average 14.5 days after the MDT decision. The average pro-
cedure duration was 89 minutes.
No enhancing abnormality was demonstrated on procedural MRI in
six cases, other technical reasons preventing successful biopsy in-
cluded posterior positioning of the lesion (n=1) and software failure
(n=1, successfully repeated).
Of 47 biopsies performed, histology showed 15(32%) B4/B5a/B5b,
4(9%) B3 and 28(60%) B1/B2. In situ disease more commonly demon-
strated non-mass like enhancement (3/4) whereas invasive disease
usually demonstrated mass features (9/10).
There were 4 ‘significant bleeds’ requiring monitoring in the depart-
ment and one vasovagal collapse which necessitated repeat procedure.
Conclusions
Our cancer detection rate (32%) is comparable to other UK centres1
and higher than studies in Europe (21%) and USA (8%)2,3, suggesting
appropriate case choice. Technical difficulties and complications were
part of the learning curve, and practices have evolved to minimize
these.
1.Teh et al. Br Can Res Supl 2012;1:03
2.Spick et al. Eur Rad 2016epub
3.Myers et al. 2015;15(2):143-152PB.44
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Introduction
Intact is a breast biopsy device that excises a breast abnormality
using vacuum and radiofrequency (RF) technology. It is licenced in
UK as a mammographic-mounted device, or a hand held device for
USS guidance. Research from USA showed complete removal of
breast abnormalities occurs frequently during Intact breast biopsy
but experience in UK is limited. We present our centre’s initial experi-
ence using Intact under USS guidance.
Methods
Selection of masses for Intact depended upon the size of mass and
the willingness of the patient to undergo the procedure, initially
under general anaesthesia (GA) immediately prior to her therapeutic
excision, and subsequently under local anaesthetic (LA). For the local
anaesthetic cases an additional criteria for U5 masses was that surgi-
cal excision under general anaesthetic was contraindicated for the
patient due to co-morbidity.Results
 19 selected breast masses in 15 women were biopsied under
USS guidance using “Intact”.
 GA: 11 masses in 9 women (January 2012–July 2013).
 LA: 8 masses in 6 women (September 2015-July 2016).
 Histology included B2 (8), B3 (4) and B5 (7) masses.
 Sizes for B3 and B5 masses: 4-17mm.
 6/7 B5 and 4/4 B3 masses - histology confirmed complete
excision with Intact.
 No complications from the Intact procedures.
Conclusion
Our initial experience suggests it is safe to perform Intact under LA
and USS guidance in an outpatient setting and that Intact offers the
potential to avoid subsequent excisional surgery for small B3 and
carefully selected small B5 masses in the future.PB.45
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Purpose/background/objectives
Vacuum assisted breast biopsy (VABB) is a minimally-invasive
modality enabling target lesions identified within breast tissue
to be either sampled or removed. A biopsy needle is advanced
percutaneously to the target under stereotactic, ultrasound or
MRI guidance, whence multiple samples are harvested. This pilot
survey explored whether differences in acute and persistent pain
intensity occurred between ultrasound and stereotactic-guided
VABBs.
Methods
A questionnaire-based survey was undertaken; basic demographic
and procedural data for patients was recorded at the time of VABB.
Participants completed a pain/analgesia diary detailing the intensity
of pain experienced and analgesia taken over the 7 day post-VABB
period. Participants were contacted at 3 months post-VABB to deter-
mine the presence of persistent pain.
Results
49 participants were recruited and 38 completed questionnaires were
returned (27 US, 11 stereo’). Statistically significant differences were
observed in the intensity of pain experienced post-biopsy by patients
who underwent US and stereo VABB on day 1; 3.4 (SD 2.8) vs 1.4 (SD
1.6) P=0.04, day 4; 1.3 (SD1.5) vs 0.2 (SD 0.6) P=0.03, day 6; 0.7 (SD
0.9) vs 0 P=0.03 and day 7; 0.7 (SD 1.0) vs 0 P=0.03. No procedural
differences existed between the groups. 3 patients (8%) reported
persistent pain at the 3-month time point, all had undergone US-
guided VABB.
Conclusions
Patients undergoing US guided VABB experienced more intense pain
in the week following biopsy than those undergoing sterotactic
guided VABB and appeared to experience more persistent pain. Fur-
ther work is required to determine the cause of these findings.
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Largest series comparing the unit current standard-of-care, Prone-
stereo(PS) Vacuum Breast Biopsy(VAB) with Digital Breast Tomosynthesis
(DBT)-guided VAB.
Background
DBT is an established mammographic technique shown to improve
the accuracy of soft tissue lesion characterisation, conspicuity and
cancer detection. VAB increases the sensitivity of pre-operative diag-
nosis, reducing upgrade rates.
Method
170 consecutive patients through the NHSBSP and symptomatic
breast service undergoing stereo-guided biopsy were recruited into 2
arms:
Multicare-Platinum-Prone-Stereotactic-Breast-Biopsy-System
Affirm-Breast- Biopsy-Guidance-System with 3D Breast Biopsy using
Hologic Selenia Dimensions
VAB was performed using the Atec-Sapphire with 9G Eviva needles. Pro-
cedure outcomes including patient comfort, time, accuracy, radiation
dose and complications were recorded.
Results
85 patients in each arm.
DBT-guided lesions: Microcalcification 72, Mass 4, Distortion 9
PS-guided lesions: Microcalcification 82, Mass 3, Distortion 0.
Benefits of DBT compared with PS VAB were:
 Shorter: Mean Room-Time 35 minutes versus 43 minutes, Mean
Compression-Time 19 minutes versus 23 minutes
 Accuracy: 97.6% versus 94%
 Lower mean total radiation dose: 14.83mGy versus 39.4mGy
 Fewer mean exposures: 7 versus 10
In addition:
 Patient pain, comfort and acceptability scores were
comparable as were operator ease of use scores
 4% required prolonged compression for haemostasis with DBT
compared with 2.5% with PS
 6% vasovagal-rate with upright DBT compared to 0% with de-
cubitus DBT or PS.
Conclusion
We demonstrate DBT-guided biopsy is a good alternative technique
to stereo-guided biopsy for soft tissue abnormalities (including those
occult on 2D and ultrasound) and microcalcifications. There is an in-
creased risk of vasovagal episodes with upright DBT, which could be
avoided with decubitus positioning or Prone-DBT.
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Introduction
The management of B3 lesions is becoming increasingly under debate
in light of criticism of over-diagnosis within breast screening. New pro-
posed guidelines throughout the UK are suggesting that surgical bi-
opsy for many B3 lesions may no longer be required.
In this audit we review all cases of B3 at initial biopsy over two five-
year cohorts.
Methods
Data was collected using the National Breast Screening System.
Results
There were 224 cases in 2005-2010 and 240 cases in 2010-2015.
Mammographically 211 lesions were microcalcifications, 182 masses,
65 distortions and 6 asymmetries.208 14G core biopsies and 256 initial vacuum biopsies were performed.
50% of patients in the first cohort underwent benign surgical biopsy
compared to 40.4% in the latter cohort.
There was a 6% upgrade to invasive malignancy and 18% upgrade
to non-invasive malignancy over the 10-year period following surgi-
cal biopsy and vacuum excisions.
The upgrade rates for each histological category were:
 Atypical duct hyperplasia 36%
 Flat epithelial atypia 28%
 Radial scar/complex sclerosing lesion with atypia 27% and with
no atypia 11%
 Papilloma with atypia 55% and with no atypia 16%
 Lobular neoplasia in situ 43%
 Suspected phyllodes tumours 8%
 Atypical apocrine adenosis 20%.
Conclusions
The results of this audit and upgrade rates are in line with the litera-
ture. Upgrade rates remain high even with first line use of vacuum
biopsy. Careful consideration is essential prior to changing current
practice.
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Following introduction of large-bore vacuum-assisted biopsy (LVB)
for diagnosis and management of B3 lesions in 2011, a prospective
database of patients was developed. Following B3 lesion diagnosis
on core biopsy, patients underwent LVB. If B5, patients had surgery;
if B3 patients underwent 5 years annual surveillance mammography
(ASM) or were discharged/returned to routine recall, depending on
the presence of epithelial atypia. Outcomes were prospectively
audited over 4 years.
B3 lesion database analysed to ascertain number of ASMs performed,
recall rate, symptomatic episodes and subsequent malignancy follow-
ing B3 diagnosis.
Between October 2011 and December 2015, 396 patients had a B3
lesion. 305 underwent second line LVB. 27 patients diagnosed with ma-
lignancy following LVB and 17 patients were upgraded to malignancy
following excision biopsy (unsuitable for LVB/pathology request).
352 patients had ASM/routine recall, together having 410 mammo-
grams performed over 4 years. 9 patients were recalled from ASM
(recall rate 2%). 20 underwent further breast investigations (19 pre-
sented symptomatically, 1 recalled from MRI high-risk surveillance).
From additional investigations 3 cancers diagnosed (1 following
high-risk surveillance MRI; 1 symptomatic presentation, 1 recall from
ASM). There were also 4 further B3 lesions and 22 benign diagnoses.
LVB for B3 lesions is an excellent alternative to excision biopsy. How-
ever, ASM has a low recall rate and cancer detection rate, with only 1
of the 3 subsequent cancers detected by mammographic surveil-
lance. This questions whether ASM is really necessary in this group of
patients. Could they be safely returned to routine recall within the
screening program?
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Introduction
IBC is an extremely aggressive breast cancer with a very poor prog-
nosis. Routine imaging includes staging CT and bone scan. PET CT is
Breast Cancer Research 2016, 18(Suppl 1):107 Page 16 of 20considered superior to CT. We reviewed cases of IBC in Leeds from
2008-2014 to determine the radiological investigations performed
and patient outcome.
Methods
From 1st February 2008 – 31st September 2014 all IBCs managed in
Leeds were retrospectively identified. The radiological investigations,
histology, subsequent management and outcome were documented.
Results
40 patients were included, 28 had an initial staging CT and 12 did
not. 4/28 (14%) had metastatic disease on initial staging CT. 19/28
(68%) had a negative staging CT and 5/28 (18%) had indeterminate
CTs due to the presence of lung nodules/liver lesions.
Of the initial 19 negative staging CT scans, 1 patient died of an unre-
lated condition. 9/18 (50%) developed metastatic disease at follow
up (6months-5years). Of the indeterminate CTs, 2/5 (40%) went on to
develop metastases at 2 months and 2 years respectively.
Conclusion
Metastatic disease is common in women presenting with IBC and ac-
curate staging is essential in guiding management and providing
prognostic information to patients. 70% of our cohort had an initial
staging CT, when all patients should be undergoing this. Of those
who received an initial negative staging scan, 32% of these had
metastatic disease within 12 months. In view of this, a PET/CT is the
recommended staging modality of choice to allow for more accurate
staging in this cohort,enabling better management in this select
group of patients.
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Introduction
Breast cancer mortality is intrinsically linked to stage at diagnosis, so
the ability to detect disease in infancy is critical. Sub optimal sensitiv-
ity and specificity of current imaging methods such as mammog-
raphy and ultrasonography result in issues such as false positive and
false negative results. Photoacoustic Imaging (PAI) represents a novel
approach to breast tissue visualisation. Non-ionizing laser pulses are
delivered to tissue and photoacoustic signals generated. Coupled
with ultrasound emission, structural imaging and functional analysis
of tissue can be determined. This pilot study assesses the potential
use of the VisualSonics Vevo LAZR PAI system in the investigation of
normal and abnormal breast tissue.
Methods
Ethical approval and informed consent was obtained. Using a 15MHz
probe, imaging of healthy and abnormal breast tissue was performed
in a tertiary symptomatic breast cancer unit (n=8). Oxygen saturation,
haemoglobin concentration and photoacoustic signal was deter-
mined for all.
Results
Characterisation of healthy breast tissue, tissue with benign path-
ology (fibroadenoma) and tissue with previously identified breast
cancer was achieved. With locations of interest determined by ultra-
sound, photoacoustic signals were assessed. Imaging to a depth of
30mm was confirmed. Comparisons in oxygen saturation were made
between breast pathology and the controls (disease free contralateral
breast).
Conclusion
Current imaging modalities in breast cancer have shortcomings. PAI
represents a novel means of both visualisation and assessment of func-
tionality of breast tissue. These preliminary findings offer an insight into
the potential of PAI in the role of breast cancer diagnosis.PB.51
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Borderline breast lesions (B3 lesions) can coexist with malignancy.
The magnitude of this risk varies between studies and lesion sub-
types. This systematic review of the literature will determine an ac-
curate estimate of the risk of invasive/in-situ malignancy identified
by surgical excision biopsy, following diagnosis of a B3 lesion at core
biopsy, within each B3 lesion subtype, to guide risk stratification and
improve management strategies.
Literature searches (MEDLINE, Embase, HMIC, Scopus and Web of
Knowledge), identified relevant studies between 1980 and 2014. Lit-
erature appraisal, meta-analysis and subgroup analysis performed to
determine malignancy risk for all subgroups of B3 lesions (Papilloma,
Radial Scar, AIDP, Lobular Neoplasia and FEA).
Searches returned 2289 citations, with 11 identified from other sources.
Duplicate, unsuitable articles and abstracts/posters/reviews were ex-
cluded leaving 183 records. From these, 54 full text articles did not
meet inclusion criteria. Meta-analysis was performed from 129 studies.
Rates of malignancy varied from 6% in a radial scar with no atypia, to
32% for a papilloma with atypia. Differences in malignancy upgrade
rates between atypical and non-atypical lesions were statistically signifi-
cant (p<0.05). Study heterogeneity could not be explained by differ-
ences in core biopsy size or year of publication, however, a significant
difference in upgrade rates to malignancy was observed between the
US and non US literature.
Many studies have assessed the risk of malignancy following diagnosis
of B3 lesions, but are often small and lack statistical power. This study
is a comprehensive, inclusive assessment of the available literature, on
which to base tailored management strategies.PB.52
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Introduction
With increasing breast cancer incidence and improved survival, opti-
mised follow-up strategies are required to maximise quality and dur-
ation of life. Whilst periodic mammography is adequate for most
older women, its sensitivity in younger women and those with dense
breasts is poor. Recurrences or new primaries in women whose ori-
ginal cancers were mammographically occult may also be occult. This
study investigates the use of supplemental follow-up imaging in
these groups.
Methods
An on-line survey of members of the British Society of Breast Radiology
was performed, enquiring about the use of supplemental imaging
follow-up, indications, modalities and numbers of women. One re-
sponse only per hospital was requested. Categorical responses were re-
classified where appropriate in line with submitted comments.
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Thirty-four valid responses from UK centres were received. Half treat
>400 women with new breast cancers per year. Screen detected can-
cers comprise <25% of cases in 15% of centres and 25-75% in 85%.
Additional imaging (mostly MRI) is offered by protocol/ad hoc in 0
and 8 (24%) units respectively for those with dense breasts, in 2 (6%)
and 10 (29%) units for young women, and in 5 (15%) and 17 (50%)
units for women with occult original cancers. Most perform <20 sup-
plemental examinations per year. Local professional consensus and
patient requests were the main reasons for providing additional
imaging.
Conclusion
Practice varies widely between units. Mammographically occult original
cancer is the commonest reason for supplemental follow-up imaging.
Further research to ascertain its cost-effectiveness is required to de-
velop evidence-based guidelines.
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Introduction
Our aim was to audit the referral of male patients to our unit, where
all males, are imaged. For the purposes of this study, we used the
following criteria to justify imaging:
i) Unilateral gynaecomastia (P2), >40 years
ii) P3-P5 or equivalent clinical description, any age
Methods
Retrospective review of all referrals for male breast imaging, over a
30-month period, from 01.01.14-30.06.16.
We recorded the referral source, clinical details including patient age,
presenting symptoms and P value, imaging findings, and histological
outcome.
Results
Over the 30-months, 518 males imaged. An increase in referral over
this period amounting to >50% per annum.
Referral source: 322/518(62%) from breast surgery, 181/518(35%) GP
and 15/518(3%) from other specialties.
Age: 13 to 93 years, bimodal peaks: 22-30 and 67-75years.
480/518 (92%) patients with P1/P2/clinically benign and U1/U2 and
no biopsy. 4 patients, all >40 years, were P2U3B2.
20/518 (4%) patients biopsied – due to either clinical or imaging
concerns.
1xB3 (in a P3U4 patient; no upgrade on sequent surgical excision)
and 14 benign conditions (all U2/U3).
Remaining 18/518 patients, all P3U1/U2, were clinically reviewed +/-
clinical core. All clinical cores were benign.
5/518 (1%) patients, all >70 years, all with P4/P5/clinically suspicious
andU3-U5. Biopsy yielded malignancy: 4xB5b and 1xmelanoma.
30% justification rate according to audit standard criteria.
Conclusion
Multisource referral, increasing numbers and a cancer detection rate
<1% in a department where all males are imaged. All clinically be-
nign cases proved benign. All cancers were suspected. Findings
strongly support the formulation of local guidelines.PB.54
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Increasing use of body CT has lead to increasing detection of inci-
dental breast lesions, creating two primary concerns within our unit:
1) that these patients experience longer delays before breast clinic
review than standard symptomatic patients.
2) That some cases could avoid clinic altogether following
specialist review of the CT/prior imaging.
49 cases over a 20 month period were reviewed to evaluate these
concerns.
Results
Time between the triggering CT and clinic attendance varied from 1
to 163 days, inpatient range 1 - 19 days, median 9; outpatients range
6 - 163 days, median 24.
Of the 49 lesions, 36 were focal masses, 5 asymmetries, 5 enlarged
nodes, 2 thickened WLE scars and one calcification. 31 biopsies were
performed. 21 lesions (68%) were suspected and proven malignant (17
masses, 3 asymmetries, 1 scar recurrence). All lesions with ancillary
suspicious findings were malignant. Hounsfield unit measurements
were higher for malignant lesions.
5 patients had unchanged screening films or prior images. Breast radi-
ologist review concluded 8 cases could have avoided clinic review as
the area of concern was normal or classically benign.
Conclusions
1) Outpatients with incidental breast lesions experience greater
delays before clinic review than the target 14 days.
2) Specialist current/prior imaging review could reduce
unnecessary clinic assessment.
A high percentage (68%) of incidental lesions were malignant. We
propose to develop a radiology:breast radiology referral pathway to
address both these issues and improve standards of care for these
patients at increased risk.PB.55
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Introduction
Male breast cancer is rare affecting < 1% of the male population. We
have observed a marked growth in the number of men referred for
imaging and propose that imaging of all men may not be necessary.
Method
Retrospective review of all men referred for imaging between 2010 -
2015. Clinical history, imaging and pathology were reviewed.
Results
Total of 452 patients. 3 patients were referred for imaging in 2010
compared with 162 in 2015. In total, 11 patients were diagnosed
with breast cancer, 2 with metastases from another primary and 3
with lymphoma.
Of these 16 patients, 2 were not given a numerical P value but the
clinical history stated suspicious mass. 12 (75%) had a P value of P3-
P5. 2 patients were clinically P2 but both had significant history: 1 of
blood stained nipple discharge and the other of previous renal cell
carcinoma.
The average age of the 16 patients was 75 years, the youngest 53
years.
In 2015, 84 (52%) patients referred for imaging were clinically graded
P2 gynaecomastia confirmed on ultrasound alone (U2). 10 patients
were clinically P2 gynaecomastia, ultrasound was indeterminate (U3)
but core biopsy confirmed gynaecomastia. The incidence of malig-
nancy was 3%.
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454 men were referred for imaging over 5 years. Malignancy was de-
tected in 3.5%. Of those patients with malignancy, 88% were clinic-
ally suspicious and all were >50 years. We propose an imaging
pathway for men based upon clinical findings/age that would be safe
and reduce unnecessary imaging and biopsy.
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Introduction
Breast cancers present with differential expression levels of hormone
receptors (ER, PR, HER2), which modern chemotherapy targets, result-
ing in 8 different subtypes. Research has shown that each subtype
presents with different histopathological features, thus affecting sur-
vival. We aim to investigate the prevalence of breast cancer receptor
subtypes between Asian and Caucasian women; and to compare
their prognostic indices.
Methods
231 Asian patients with invasive breast carcinoma (IBC), age-matched
with equal numbers of Caucasian patients; are included in this retro-
spective cohort study (n=462). Receptor profiles and histopathological
features for each case have been extracted from medical records along
with calculation of Nottingham Prognostic Index (NPI).
Results
Across all receptor subtypes, Asian patients presented with higher
NPI; lymph node status; invasive grade; and larger tumour sizes
(p<0.005). They have higher prevalence of HER2-positive subtypes
(30.3%, p=0.002); whereas Caucasian patients have a higher propor-
tion of ER+/PR+/HER2- subtype (p=0.030), which is associated with
favourable prognostic indices. TNBC prevalence is similar in both
groups, demonstrating the highest proportion of grade 3 tumours,
while HER2-positive subtypes demonstrated the highest NPI. Fur-
thermore, prognostic indices were worse in younger patients.
Conclusion
Consistent with recent literature, our study provides evidence that
Asian patients are more prone to HER2-overexpressing breast cancer,
but not TNBC subtypes, Also, poor clinico-pathological features were
associated with these 2 subtypes, correlating to a poor prognosis.
Given the poor prognostic indices they present with and high treat-
ment costs involved with these subtypes, our results have implica-
tions for clinical care and future research.
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Background
Our institution performs Tecnitium-99m bone scan in addition to CT
thorax, abdomen and pelvis as a part of routine staging of patients
with locally advanced or aggressive breast cancer. The purpose of
this study is to 1) determine if bone scan offers any additional infor-
mation over CT and 2) evaluate the potential cost effectiveness of
performing extended coverage CT alone, without additional bone
scan.
Method
Retrospective review of cases at a single university hospital for a
period of 30 months was undertaken. Inclusion criteria: CT and bonescan within 2 weeks of each other with a new diagnosis of breast
cancer. Exclusion criteria: previous malignancy, symptomatic patients,
contralateral breast malignancy.
Results
113 patients included, all female.
In the bone scan group there were 5 false negatives and 1 false posi-
tive. In the CT group there was 1 false negative.
Conclusion
Our experience shows that CT is highly accurate in staging asymp-
tomatic women with suspected bony metastasis. Staging CT picked
up 95% of bony metastatic lesions. Bone scan failed to identify 5
(23%) bone metastases and overcalled a single diagnosis of metasta-
sis. At our trust a Tc-99m bone scan costs £246 and is significantly
more expensive than CT costing £147. There is huge potential cost
saving by removing bone scan from routine work up of this patient
group. Instead, extended coverage CT (base of skull to mid femur) at
a cost of £164 may be performed. This will reduce overall radiation
dose to the patient and is economically beneficial.PB.59
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Background
Royal College of Radiologists guidelines from 2013 recommends con-
trast enhanced CT of chest, abdomen and pelvis for breast cancer
patients with suspected metastasis, which may obviate the need for
bone scan in asymptomatic patients.
Aim
The purpose of this study is to perform a head to head comparison
of bone scan and CT scan in breast cancer patients. It aims to evalu-
ate if any extra bony lesions were picked up with bone scan, and
assess the number of false negative bone scan or CT scans, if any.
Method: Between June 2006 and January 2016, 164 breast cancer
patients had staging investigations (either both CT and bone scans
or bone scan only or CT only). All images and reports on PACS were
evaluated retrospectively.
Results
104/164 patients had both CT and bone scan within one month of
each other. Among these 104, 48 had both investigations completely
normal while 14 had concordant abnormal findings.
CT picked up extra metastatic soft tissue findings(mostly lung or
liver) in 25(23.8%). Bone scans picked extra abnormal findings in
5(4.8%),either skull or peripheral bony metastasis, but all 5 had other
metastatic lesions visible on CT, either within axial skeleton or soft
tissues. CT and bone scan had equivocal findings in 14(13.4%) and
12(11.5%) patients respectively. There were 3(2.8%) false negative
bone scans.
Conclusion
CT picked up substantial number of extra soft tissue metastasis. Bone
scan did not add to the total number of metastatic patients. Our
findings suggest routine bone scan in asymptomatic patients with
breast cancer is inappropriate.PB.60
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Background
Longterm follow up mammograms of patients post surgery form a con-
siderable bulk of the reporting in a symptomatic breast unit. Recalls
from this group add considerably to patient anxiety, and contribute to
Breast Cancer Research 2016, 18(Suppl 1):107 Page 19 of 20workload, taking up valuable appointment time for spot views, ultra-
sound and biopsy.
Aim
A decision was made to second read all recalls from the LTFU
group; arbitration by a third consultant was used as a deciding vote
in case of disagreement. All second reads and arbitrations were re-
corded in a diary - this has been ongoing for a year. All cases were
analysed for presence or absence of malignancy when recalled,
retrospectively.
Results
Of 93 LTFU patients recalled from June 2015 to May 2016, 77
patients were recalled after arbitration. 58 of these patients (75.3%)
were returned to routine followup following arbitration; 19 patients
(24.7%) were recalled following arbitration. 3 malignant cases (16%)
were noted in the recall group post arbitration; 16 cases (84%) were
benign. The most commonly arbitrated lesion was opacity, in 45%;
37% were recalled for an opacity.
Conclusion
Second reading with arbitration, as in screening, is a valuable tool to re-
duce number of recalls in the LTFU group, allowing 75% of arbitrated
cases to be returned to normal followup. This reduces patient anxiety,
and frees up valuable time for assessment of true positive malignant re-
calls. In the absence of established guidelines, the screening recall rates
of 4% for incident round and 7% for prevalent round can be used to
compare symptomatic recall rate in an instutution.PB.61
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Introduction
Digital Breast Tomosynthesis is established as a problem-solving tool
within NHS screening. Recent publications have examined the impact
of DBT as an assessment tool within the symptomatic setting. To
date, literature has not reported on the impact of DBT as a baseline
study in this scenario although internationally many centres have
adopted this practice. Our centre installed a Hologic Dimensions
Tomographic unit in May 2015. Upon installation, DBT replaced Full
Field Digital Mammography (FFDM) as the baseline tool for symp-
tomatic and surveillance patients.
Aim
To establish if the number of M3 reports have increased or de-
creased and to quantify the positive predictive value of M3 reports.
Methods
DBT mammographic reports over 12months were reviewed and com-
pared with FFDM reports in the previous 12month period, evaluating
‘M3' reports and their subsequent up- or downgrading. Cases were
evaluated to identify the following - additional mammographic views,
ultrasound grading, histopathological classification and final diagnosis.
Results
There were less M3 reports overall. Of the M3 reports, more were
true positive than in the previous year. Within this specific cohort we
identified a 10.10% increased likelihood of ultrasound upgrade fol-
lowing DBT compared with FFDM, a 25.7% increased likelihood of
histological upgrade and a 7.1% increase in ability to predict malig-
nancy using DBT compared to FFDM.
Discussion
We acknowledge the limitations in terms of design and cohort but
the results of this small centre study are in line with previous screen-
ing studies and substantiate the use of DBT as a baseline tool in the
symptomatic setting.PB.62
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Introduction
Traditionally mammography has been used as the first-line imaging
test in patients with breast symptoms aged over 40 years of either
sex. Some centres advocate ‘ultrasound first’ in men instead. This
study assessed whether mammography correctly identified cancers
in a ‘mammography first’ unit, the imaging modalities used and the
relationship of gynaecomastia to imaging and breast cancer.
Methods
We looked at male breast cancers from 2010-2014, in addition to the
number of men referred to our breast unit who were imaged with
mammography, ultrasound, or both in 2014, noting whether they had
gynaecomastia.
Results
From 2010-2014, 19 men had breast cancer, 2 bilaterally. All were de-
tected on imaging, including 2 that were unsuspected clinically. Only
1 occurred in a man with clinically simple gynaecomastia. In 2014,
207 men aged 40+ came to our unit and 143 were imaged. 71 had
mammography without ultrasound, 63 had both and 9 just ultra-
sound. Gynaecomastia was the most common indication and finding,
being seen in 95 men, representing 68% of those imaged. Assuming
2014 was representative of 2010-2014, 475 men with gynaecomastia
needed imaging to find one unsuspected breast cancer, a lower de-
tection rate than in the NHS breast screening programme.
Conclusions
Neither mammography nor ultrasound missed or misclassified any
cancers. This study supports using mammography or ultrasound first-
line to image men aged 40+, depending on local resources. Gynae-
comastia was the major imaging indicator/finding. There should be
stricter adherence to guidelines that limit breast imaging for gynae-
comastia, as it rarely masks cancer.
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Introduction
The primary imaging workload in the breast unit is within the con-
text of the symptomatic fast track clinic or screening assessment
clinic. These usually have defined numbers of patients. In addition
there is a significant increasing workload of extra patients who re-
quire imaging and invasive procedures via other pathways, which we
aimed to quantify.
Methods
The data was identified retrospectively from the Computerised Radi-
ology Information System (CRIS) and recorded on a spreadsheet.
Information was collected on the number of extra patients who were
imaged and reviewed by the Breast Radiologists in addition to their
booked workload during the months of May and June 2016.
Results
Over a two month period there were an additional 60 patients. These
patients were referred from a wide variety of departments within the
hospital, although the majority were referred through the breast
surgeons.
A total of 48 ultrasound examinations and 21 mammograms were
performed and reported on these patients. The additional procedures
Breast Cancer Research 2016, 18(Suppl 1):107 Page 20 of 20performed were also recorded, comprising 6 core biopsies, 2 fine
needle aspirations, 4 seroma aspirations and 3 abscess drainages.
Conclusion
There is a significant “extra” workload performed during the working
week by Breast Radiologists which may not be reflected in funding
streams or be accounted for in job plans. Extra imaging represents a
significant workload; the equivalent of 3-4 symptomatic clinics a
month. With escalating trends for imaging and a greater reliance on
image-guided seroma and abscess drainage, it is likely that this will
increase.PB.64
Male breast patient imaging: what is an appropriate pathway?
Muthyala Sreenivas
UHCW NHS Trust, Coventry, UK
Breast Cancer Research 2016, 18(Suppl 1):PB.64
Background
Breast cancer in much less common in men when compared to
women and many cancers occurs in men over 50 years of age. Rou-
tine usage of imaging in men presenting via fast track clinic may be
not be appropriate and a better stratification of patients for imaging
is warranted.
Methods
Retrospective data between 2010 to 2014 from hospital RIS identified
a total of 500 male patients of varying ages who were all referred for
imaging. Various patient demographic details were recorded and
outcomes of triple assessment correlated.
Results
Average age of the patients was 45 years. There was no consistency
as to what imaging was used. 130 patients received US only, 12 re-
ceived mammograms only and 358 received both US and mammo-
grams. 54 US core biopsies and one stereocore biopsy was
performed. 488 patients were scored P2 on clinical examination of
which none had a cancer and imaging and pathology findings
(where necessary) were benign. 8 were scored P3 and there were
two cancers in this group. All three P4 cases were benign on imaging
and pathology. There was a single P5 case which was malignant on
imaging and on pathology. Overall three malignancies were detected
which were all in men over 70 years of age.
Conclusion
Routine imaging of men is not warranted. An alternate more cost ef-
fective pathway was devised and is being implemented at UHCW.PB.65
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Introduction
Since 2012, in keeping with ‘Best Practice Guidelines’ Forth Valley
breast-team has changed the practice and we don’t use mammo-
grams as regular adjunct to assessment in women in age-group 35-
40years. Not all centres in Scotland are following this guideline and
this results in anxiety over potential missed cancer diagnosis.
Methods
Caldicott approval was obtained. List of breast cancers diagnosed in
year 2013 was obtained from the local audit department. Radiology
database and clinical portal were searched for relevant breast im-
aging and clinical information.
Results
3610 women were imaged in year 2013 and 242 cancers were
diagnosed.
310 of these women were in the age-group 35-40 years and 11 can-
cers were diagnosed.
Analysing the data for these 11 cases, 9 had abnormal clinical and
ultrasound findings. Mammograms were not crucial to reach the
diagnosis.
1 case was clinically benign but had suspicious ultrasound findings.
Lesion was occult on subsequent mammograms.
In the remaining case, only abnormality was incidental lymphnode
which was metastatic on biopsy. Malignant calcification was seen on
subsequent mammography. This is the only case where potentially
we could have missed the diagnosis.
Conclusion
In this study, almost all cancers were picked-up on clinical-examination
or ultrasound. There was a single case where without upfront mam-
mography we could potentially have missed the diagnosis of cancer.
This was picked-up on diligent scanning of the whole quadrant.
In our practice, it is safe to limit the use of mammography in the
age-group 35-40years and continue using ultrasound as the first line
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